{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:23:42Z","timestamp":1794266622413,"version":"4.9.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.lungcan.2023.107284","type":"journal-article","created":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T10:08:56Z","timestamp":1687687736000},"page":"107284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Stereotactic Body Radiotherapy for Lung Oligo-metastases: Systematic Review and International Stereotactic Radiosurgery Society Practice Guidelines"],"prefix":"10.1016","volume":"182","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4433-2552","authenticated-orcid":false,"given":"Michael","family":"Mayinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupesh","family":"Kotecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Sahgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Sook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon S.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander V.","family":"Louie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Scorsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Slotman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7146-9071","authenticated-orcid":false,"given":"Matthias","family":"Guckenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2023.107284_b0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2023.107284_b0010","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2023.107284_b0015","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2020.04.003","article-title":"Defining oligometastatic disease from a radiation oncology perspective: an ESTRO-ASTRO consensus document","volume":"148","author":"Lievens","year":"2020","journal-title":"Radiother. Oncol."},{"issue":"946\u2013949","key":"10.1016\/j.lungcan.2023.107284_b0020","first-page":"20140109","article-title":"Pulmonary metastasectomy: what is the practice and where is the evidence for effectiveness?","volume":"69","author":"Treasure","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.lungcan.2023.107284_b0025","unstructured":"D.R. Gomez, C. Tang, J. Zhang, et al. Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non\u2013small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study. 2019; 37: 1558."},{"issue":"10185","key":"10.1016\/j.lungcan.2023.107284_b0030","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.lungcan.2023.107284_b0035","doi-asserted-by":"crossref","first-page":"e173501","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative radiotherapy for limited metastatic non\u2013small-cell lung cancer: a phase 2 randomized clinical trial","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.lungcan.2023.107284_b0040","first-page":"20220130","article-title":"Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated NSCLC","author":"Wang","year":"2022","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.lungcan.2023.107284_b0045","unstructured":"Centre for Evidence-Based Medicine (CEBM) UoO. OCEBM Levels of Evidence 2022."},{"issue":"7","key":"10.1016\/j.lungcan.2023.107284_b0050","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.lungcan.2023.107284_b0055","first-page":"58","article-title":"Lung metastases treated with stereotactic ablative radiation therapy in oligometastatic colorectal cancer patients: outcomes and prognostic factors after long-term follow-up","volume":"16","author":"Agolli","year":"2017","journal-title":"Clin. Colorectal Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2023.107284_b0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/jrr\/rrv063","article-title":"Stereotactic body radiotherapy for lung metastases as oligo-recurrence: a single institutional study","volume":"57","author":"Aoki","year":"2016","journal-title":"J. Radiat. Res."},{"issue":"1","key":"10.1016\/j.lungcan.2023.107284_b0065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jso.24268","article-title":"Efficacy and safety of stereotactic body radiation therapy for the treatment of pulmonary metastases from sarcoma: a potential alternative to resection: SBRT for Sarcoma Pulmonary Metastases","volume":"114","author":"Baumann","year":"2016","journal-title":"J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2023.107284_b0070","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s12885-020-06906-1","article-title":"Stereotactic robotic body radiotherapy for patients with oligorecurrent pulmonary metastases","volume":"20","author":"Berkovic","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lungcan.2023.107284_b0075","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4149\/neo_2018_180731N558","article-title":"Ablative dose stereotactic body radiation therapy for oligometastatic disease: a prospective single institution study","volume":"66","author":"Burkon","year":"2019","journal-title":"Neoplasma"},{"issue":"4","key":"10.1016\/j.lungcan.2023.107284_b0080","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.21037\/tlcr-20-867","article-title":"Pulmonary oligometastases treated by stereotactic body radiation therapy (SBRT): a single institution\u2019s experience","volume":"9","author":"Chai","year":"2020","journal-title":"Transl Lung Cancer Res"},{"issue":"1","key":"10.1016\/j.lungcan.2023.107284_b0085","doi-asserted-by":"crossref","first-page":"S373","DOI":"10.1016\/j.ijrobp.2014.05.1202","article-title":"Stereotactive ablative radiation therapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach","volume":"90","author":"Comito","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"8","key":"10.1016\/j.lungcan.2023.107284_b0090","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s12094-015-1291-1","article-title":"Lung metastases in oligometastatic patients: outcome with stereotactic body radiation therapy (SBRT)","volume":"17","author":"Garc\u00eda-Cabezas","year":"2015","journal-title":"Clin. Transl. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2023.107284_b0095","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00066-012-0290-1","article-title":"Stereotactic body radiotherapy for pulmonary metastases: prognostic factors and adverse respiratory events","volume":"189","author":"Inoue","year":"2013","journal-title":"Strahlenther. Onkol."},{"issue":"1","key":"10.1016\/j.lungcan.2023.107284_b0100","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-015-0546-x","article-title":"Clinical efficacy of stereotactic ablative radiotherapy for lung metastases arising from colorectal cancer","volume":"10","author":"Jung","year":"2015","journal-title":"Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2023.107284_b0105","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/s12885-020-06892-4","article-title":"Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases","volume":"20","author":"Kalinauskaite","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lungcan.2023.107284_b0110","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3389\/fonc.2019.01080","article-title":"Prognostic factors and optimal response interval for stereotactic body radiotherapy in patients with lung oligometastases or oligoprogression from colorectal cancer","volume":"9","author":"Li","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lungcan.2023.107284_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/9132359","article-title":"Treatment of sarcoma lung metastases with stereotactic body radiotherapy","volume":"2018","author":"Lindsay","year":"2018","journal-title":"Sarcoma"},{"key":"10.1016\/j.lungcan.2023.107284_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-016-0608-8","article-title":"Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases","volume":"11","author":"Lischalk","year":"2016","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.lungcan.2023.107284_b0125","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12040885","article-title":"Stereotactic radiotherapy for ultra-central lung oligometastases in non-small-cell lung cancer","volume":"12","author":"Loi","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.lungcan.2023.107284_b0130","unstructured":"A. Mihai, Y. Mu, J. Armstrong, et al. Patients with colorectal lung oligometastases (L-OMD) treated by dose adapted SABR at diagnosis of oligometastatic disease have better outcomes than patients previously treated for their metastatic disease. J. Radiosurg. SBRT 2017; 5: 43-53. 2018\/01\/04."},{"issue":"5","key":"10.1016\/j.lungcan.2023.107284_b0135","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ejca.2015.01.061","article-title":"Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma","volume":"51","author":"Navarria","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.lungcan.2023.107284_b0140","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.radonc.2020.03.018","article-title":"Quality of life after pulmonary stereotactic fractionated radiotherapy (SBRT): results of the phase II STRIPE trial","volume":"148","author":"Nestle","year":"2020","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.lungcan.2023.107284_b0145","doi-asserted-by":"crossref","first-page":"S1836","DOI":"10.1016\/j.jtho.2017.09.528","article-title":"Pulmonary oligometastases treated by stereotactic body radiation therapy (SBRT): a nationwide survey of 1,378 patients","volume":"12","author":"Niibe","year":"2017","journal-title":"J. Thoracic Oncol."},{"key":"10.1016\/j.lungcan.2023.107284_b0150","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.lungcan.2018.06.018","article-title":"30 Gy single dose stereotactic body radiation therapy (SBRT): Report on outcome in a large series of patients with lung oligometastatic disease","volume":"122","author":"Osti","year":"2018","journal-title":"Lung Cancer"},{"issue":"8","key":"10.1016\/j.lungcan.2023.107284_b0155","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1080\/0284186X.2018.1445285","article-title":"Factors affecting local control of pulmonary oligometastases treated with stereotactic body radiotherapy","volume":"57","author":"Sharma","year":"2018","journal-title":"Acta Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2023.107284_b0160","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.clon.2015.01.004","article-title":"Comparison of single-fraction and multi-fraction stereotactic radiotherapy for patients with 18F-fluorodeoxyglucose positron emission tomography-staged pulmonary oligometastases","volume":"27","author":"Siva","year":"2015","journal-title":"Clin. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2023.107284_b0165","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.radonc.2016.04.020","article-title":"Motion management during SBRT for oligometastatic cancer: results of a prospective phase II trial","volume":"119","author":"Van den Begin","year":"2016","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.lungcan.2023.107284_b0170","first-page":"407","article-title":"Clinical outcomes of cyberknife stereotactic radiosurgery for lung metastases","volume":"7","author":"Wang","year":"2015","journal-title":"J. Thoracic Dis."},{"issue":"3","key":"10.1016\/j.lungcan.2023.107284_b0175","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ijrobp.2014.10.046","article-title":"Stereotactic ablative radiation therapy as first local therapy for lung oligometastases from colorectal cancer: a single-institution cohort study","volume":"91","author":"Filippi","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.lungcan.2023.107284_b0180","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lungcan.2011.04.021","article-title":"Stereotactic body radiation therapy for lung metastases","volume":"75","author":"Ricardi","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2023.107284_b0185","unstructured":"Patton C and Bradfield L. ASTRO Clinical Practice Guideline Methodology Guide. 2019."},{"key":"10.1016\/j.lungcan.2023.107284_b0190","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/COC.0000000000000220","article-title":"Stereotactic body radiotherapy for lung metastases from colorectal cancer: prognostic factors for disease control and survival","volume":"41","author":"Qiu","year":"2018","journal-title":"Am. J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2023.107284_b0195","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.radonc.2018.07.001","article-title":"The safety and effectiveness of stereotactic body radiotherapy for central versus ultracentral lung tumors","volume":"129","author":"Chang","year":"2018","journal-title":"Radiother. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2023.107284_b0200","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ijrobp.2017.02.093","article-title":"Stereotactic ablative radiation therapy for pulmonary metastases: histology, dose, and indication matter","volume":"98","author":"Helou","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"10","key":"10.1016\/j.lungcan.2023.107284_b0205","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1001\/jamaoncol.2021.2939","article-title":"Single-fraction vs multifraction stereotactic ablative body radiotherapy for pulmonary oligometastases (SAFRON II): the trans tasman radiation oncology group 13.01 phase 2 randomized clinical trial","volume":"7","author":"Siva","year":"2021","journal-title":"JAMA Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2023.107284_b0210","doi-asserted-by":"crossref","first-page":"e667","DOI":"10.1016\/j.cllc.2019.06.024","article-title":"Long-term Follow-up and patterns of recurrence of patients with oligometastatic NSCLC treated with pulmonary SBRT","volume":"20","author":"H\u00f6rner-Rieber","year":"2019","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.lungcan.2023.107284_b0215","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.21037\/jtd.2019.02.80","article-title":"Stereotactic body radiation therapy versus metastasectomy for oligometastases","volume":"11","author":"Qiu","year":"2019","journal-title":"J. Thorac. Dis."},{"issue":"4","key":"10.1016\/j.lungcan.2023.107284_b0220","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.ijrobp.2005.03.073","article-title":"Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study","volume":"63","author":"McGarry","year":"2005","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.lungcan.2023.107284_b0225","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.prro.2015.09.012","article-title":"Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree","volume":"6","author":"Haseltine","year":"2016","journal-title":"Pract. Radiat. Oncol."},{"key":"10.1016\/j.lungcan.2023.107284_b0230","doi-asserted-by":"crossref","unstructured":"S. Siva, P. Sakyanun, T. Mai, et al. Long-Term Outcomes of TROG 13.01 SAFRON II randomized trial of single- versus multifraction stereotactic ablative body radiotherapy for pulmonary oligometastases. J. Clin. Oncol. 2023: JCO2300150. 20230514. DOI: 10.1200\/JCO.23.00150.","DOI":"10.1200\/JCO.23.00150"},{"issue":"3","key":"10.1016\/j.lungcan.2023.107284_b0235","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ijrobp.2006.02.019","article-title":"Magnitude and clinical relevance of translational and rotational patient setup errors: a cone-beam CT study","volume":"65","author":"Guckenberger","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2023.107284_b0240","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.radonc.2021.11.030","article-title":"Single-isocenter versus multiple-isocenters for multiple lung metastases: evaluation of lung dose","volume":"166","author":"van Timmeren","year":"2022","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.lungcan.2023.107284_b0245","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.radonc.2021.07.001","article-title":"Margin calculation for multiple lung metastases treated with single-isocenter SBRT","volume":"162","author":"van Timmeren","year":"2021","journal-title":"Radiother. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2023.107284_b0250","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.radonc.2013.06.045","article-title":"Lung stereotactic body radiation therapy (SBRT) delivered over 4 or 11 days: a comparison of acute toxicity and quality of life","volume":"108","author":"Jain","year":"2013","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.lungcan.2023.107284_b0255","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016950022300822X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016950022300822X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:05:24Z","timestamp":1759237524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016950022300822X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":51,"alternative-id":["S016950022300822X"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2023.107284","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereotactic Body Radiotherapy for Lung Oligo-metastases: Systematic Review and International Stereotactic Radiosurgery Society Practice Guidelines","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2023.107284","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107284"}}